Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)

China · Delayed Price · Currency is CNY

8.31

-0.12 (-1.42%)

Oct 14, 2026, 1:35 PM CST

Market Cap	1.98B -20.6%
Revenue (ttm)	723.26M -6.6%
Net Income	8.21M -70.4%
EPS	0.04 -71.0%
Shares Out	237.74M
PE Ratio	237.57
Forward PE	n/a
Dividend	0.03 (0.36%)
Ex-Dividend Date	May 27, 2026

Volume	2,834,900
Open	8.45
Previous Close	8.43
Day's Range	8.28 - 8.45
52-Week Range	7.04 - 13.09
Beta	0.01
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHE:002873

Guiyang Xintian Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of new traditional Chinese medicines in China. The company offers products in various dosage forms, including hard capsules, oral solutions, granules, gels, tablets, syrups, tinctures, lotions, medicated wines, and elixirs. Its products are used for the treatment of gynecological, urinary tract, breast, thyroid, cardiovascular, anti-tumor, and dental diseases, as well as for oral health; and cold, heat-clearing, an... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1995

Employees 1,388

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002873

Full Company Profile

Financial Performance

In 2025, SHE:002873's revenue was 749.72 million, a decrease of -12.57% compared to the previous year's 857.55 million. Earnings were 9.11 million, a decrease of -82.59%.

Financial Statements